Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $69.9100 (-5.76%) ($68.6700 - $77.0500) on Wed. Mar. 25, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.67% (three month average) | RSI | 35 | Latest Price | $69.9100(-5.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.5% a day on average for past five trading days. | Weekly Trend | LGND declines -14.2% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(54%) IWC(53%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -2.835% in a week (0% probabilities). VIXM(-31%) VXX(-18%) TLT(-13%) UUP(-5%) IGOV(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.835% (StdDev 5.67%) | Hourly BBV | 0 () | Intraday Trend | -5.8% | | | |
|
1 - 5 Day Possible Target | $47.18(-32.51%) | Resistance Level | $87.15 | 5 Day Moving Average | $73.7(-5.14%) | 10 Day Moving Average | $74.84(-6.59%) | 20 Day Moving Average | $87.15(-19.78%) | To recent high | -35.2% | To recent low | 10.3% | Market Cap | $1.124b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |